Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database

Atypical hemolytic uremic syndrome (aHUS), an important cause of acute kidney injury (AKI), is characterized by dysregulation of the alternative complement pathway. Autoantibodies to factor H (FH), a chief regulator of this pathway, account for a distinct subgroup. While high anti-FH titers predict...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2019-06, Vol.10, p.1282-1282
Hauptverfasser: Puraswani, Mamta, Khandelwal, Priyanka, Saini, Himanshi, Saini, Savita, Gurjar, Bahadur Singh, Sinha, Aditi, Shende, Rajashri Pramod, Maiti, Tushar Kanti, Singh, Abhishek Kumar, Kanga, Uma, Ali, Uma, Agarwal, Indira, Anand, Kanav, Prasad, Narayan, Rajendran, Padmaraj, Sinha, Rajiv, Vasudevan, Anil, Saxena, Anita, Agarwal, Sanjay, Hari, Pankaj, Sahu, Arvind, Rath, Satyajit, Bagga, Arvind
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Atypical hemolytic uremic syndrome (aHUS), an important cause of acute kidney injury (AKI), is characterized by dysregulation of the alternative complement pathway. Autoantibodies to factor H (FH), a chief regulator of this pathway, account for a distinct subgroup. While high anti-FH titers predict relapse, they do not correlate well with disease activity and their functional characterization is required. Of 781 patients
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2019.01282